Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-EPOCH + Ibrutinib for Richter Transformation
NCT04992377Phase 2Unknown
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Aug 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibrutinib in Richter's syndrome (RS), sponsored by Institute of Hematology and Blood Diseases Hospital. Status: unknown.
02
Drugs
ibrutinib
03
Conditions
Richter's syndrome (RS)
Beyond the preview
Go deeper on NCT04992377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04992377.